Literature DB >> 19620707

Vinyl sulfones as antiparasitic agents and a structural basis for drug design.

Iain D Kerr1, Ji H Lee, Christopher J Farady, Rachael Marion, Mathias Rickert, Mohammed Sajid, Kailash C Pandey, Conor R Caffrey, Jennifer Legac, Elizabeth Hansell, James H McKerrow, Charles S Craik, Philip J Rosenthal, Linda S Brinen.   

Abstract

Cysteine proteases of the papain superfamily are implicated in a number of cellular processes and are important virulence factors in the pathogenesis of parasitic disease. These enzymes have therefore emerged as promising targets for antiparasitic drugs. We report the crystal structures of three major parasite cysteine proteases, cruzain, falcipain-3, and the first reported structure of rhodesain, in complex with a class of potent, small molecule, cysteine protease inhibitors, the vinyl sulfones. These data, in conjunction with comparative inhibition kinetics, provide insight into the molecular mechanisms that drive cysteine protease inhibition by vinyl sulfones, the binding specificity of these important proteases and the potential of vinyl sulfones as antiparasitic drugs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19620707      PMCID: PMC2757971          DOI: 10.1074/jbc.M109.014340

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

Review 1.  Biochemical and molecular mechanisms of drug resistance in parasites.

Authors:  M Ouellette
Journal:  Trop Med Int Health       Date:  2001-11       Impact factor: 2.622

2.  A target within the target: probing cruzain's P1' site to define structural determinants for the Chagas' disease protease.

Authors:  L S Brinen; E Hansell; J Cheng; W R Roush; J H McKerrow; R J Fletterick
Journal:  Structure       Date:  2000-08-15       Impact factor: 5.006

3.  Crystal structures of reversible ketone-Based inhibitors of the cysteine protease cruzain.

Authors:  Lily Huang; Linda S Brinen; Jonathan A Ellman
Journal:  Bioorg Med Chem       Date:  2003-01-02       Impact factor: 3.641

4.  Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3.

Authors:  P S Sijwali; B R Shenai; J Gut; A Singh; P J Rosenthal
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

5.  Folding of the Plasmodium falciparum cysteine protease falcipain-2 is mediated by a chaperone-like peptide and not the prodomain.

Authors:  Puran S Sijwali; Bhaskar R Shenai; Philip J Rosenthal
Journal:  J Biol Chem       Date:  2002-02-04       Impact factor: 5.157

Review 6.  Cysteine proteinases of trypanosome parasites: novel targets for chemotherapy.

Authors:  C R Caffrey; S Scory; D Steverding
Journal:  Curr Drug Targets       Date:  2000-09       Impact factor: 3.465

Review 7.  [Trypanocidal effect of cysteine protease inhibitors in vitro and in vivo in experimental Chagas disease].

Authors:  J C Engel; P S Doyle; J H McKerrow
Journal:  Medicina (B Aires)       Date:  1999       Impact factor: 0.653

8.  Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries.

Authors:  J L Harris; B J Backes; F Leonetti; S Mahrus; J A Ellman; C S Craik
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

9.  Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Trypanosoma brucei rhodesiense.

Authors:  C R Caffrey; E Hansell; K D Lucas; L S Brinen; A Alvarez Hernandez; J Cheng; S L Gwaltney; W R Roush; Y D Stierhof; M Bogyo; D Steverding; J H McKerrow
Journal:  Mol Biochem Parasitol       Date:  2001-11       Impact factor: 1.759

10.  In vitro evaluation of the disposition of A novel cysteine protease inhibitor.

Authors:  W Jacobsen; U Christians; L Z Benet
Journal:  Drug Metab Dispos       Date:  2000-11       Impact factor: 3.922

View more
  54 in total

1.  Structural basis for inhibition of cathepsin B drug target from the human blood fluke, Schistosoma mansoni.

Authors:  Adéla Jílková; Pavlína Rezácová; Martin Lepsík; Martin Horn; Jana Váchová; Jindrich Fanfrlík; Jirí Brynda; James H McKerrow; Conor R Caffrey; Michael Mares
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

2.  Vinyl sulfone-based inhibitors of trypanosomal cysteine protease rhodesain with improved antitrypanosomal activities.

Authors:  Huaisheng Zhang; Jasmine Collins; Rogers Nyamwihura; Olamide Crown; Oluwatomi Ajayi; Ifedayo Victor Ogungbe
Journal:  Bioorg Med Chem Lett       Date:  2020-04-28       Impact factor: 2.823

3.  Automated molecule editing in molecular design.

Authors:  Peter W Kenny; Carlos A Montanari; Igor M Prokopczyk; Fernanda A Sala; Geraldo Rodrigues Sartori
Journal:  J Comput Aided Mol Des       Date:  2013-09-04       Impact factor: 3.686

4.  In vitro and in vivo trypanocidal effects of the cyclopalladated compound 7a, a drug candidate for treatment of Chagas' disease.

Authors:  Alisson L Matsuo; Luis S Silva; Ana C Torrecilhas; Bruno S Pascoalino; Thiago C Ramos; Elaine G Rodrigues; Sergio Schenkman; Antonio C F Caires; Luiz R Travassos
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

5.  Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome.

Authors:  Christine Juliana; Teresa Fernandes-Alnemri; Jianghong Wu; Pinaki Datta; Leobaldo Solorzano; Je-Wook Yu; Rong Meng; Andrew A Quong; Eicke Latz; Charles P Scott; Emad S Alnemri
Journal:  J Biol Chem       Date:  2010-01-21       Impact factor: 5.157

6.  Nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors as promising new leads for Chagas disease chemotherapy.

Authors:  Katrien Brak; Iain D Kerr; Kimberly T Barrett; Nobuhiro Fuchi; Moumita Debnath; Kenny Ang; Juan C Engel; James H McKerrow; Patricia S Doyle; Linda S Brinen; Jonathan A Ellman
Journal:  J Med Chem       Date:  2010-02-25       Impact factor: 7.446

7.  Computer-aided identification of Trypanosoma brucei uridine diphosphate galactose 4'-epimerase inhibitors: toward the development of novel therapies for African sleeping sickness.

Authors:  Jacob D Durrant; Michael D Urbaniak; Michael A J Ferguson; J Andrew McCammon
Journal:  J Med Chem       Date:  2010-07-08       Impact factor: 7.446

8.  Crystal Structures of TbCatB and rhodesain, potential chemotherapeutic targets and major cysteine proteases of Trypanosoma brucei.

Authors:  Iain D Kerr; Peng Wu; Rachael Marion-Tsukamaki; Zachary B Mackey; Linda S Brinen
Journal:  PLoS Negl Trop Dis       Date:  2010-06-08

9.  Computational identification of uncharacterized cruzain binding sites.

Authors:  Jacob D Durrant; Henrik Keränen; Benjamin A Wilson; J Andrew McCammon
Journal:  PLoS Negl Trop Dis       Date:  2010-05-11

10.  In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi.

Authors:  Yen Ting Chen; Linda S Brinen; Iain D Kerr; Elizabeth Hansell; Patricia S Doyle; James H McKerrow; William R Roush
Journal:  PLoS Negl Trop Dis       Date:  2010-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.